NCT04706754Recruiting
Pan-Canadian Lung Cancer Observational Study (PALEOS)
Source: ClinicalTrials.gov · Last updated 1 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
A multicenter, ambispective observational study focusing on patients diagnosed with lung cancer in Canada identified after January 1, 2000 inclusive. This data will be combined with that from deceased patients identified.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 25000 (estimated)
- First submitted
- 20 May 2020
- Start date
- 7 Apr 2020
- Primary completion date
- 7 Apr 2040
- Lead sponsor
- William Osler Health System
- Diseases
- Lung cancer
- NCT number
- NCT04706754
What you commit to
- Study type: Observational
- Planned participants: 25000
- From 7 Apr 2020 to the primary completion date, 7 Apr 2040
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients that decline to provide informed consent.
Who the study is looking for
- Adults aged 18 years or older having a documented lung cancer diagnosis since 2000.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Milena (Lynn) Vicente Coordinator of this site? Confirm its status | Brampton | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.